Filing Details
- Accession Number:
- 0001209191-20-051891
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2020-09-24 16:21:08
- Reporting Period:
- 2020-09-22
- Accepted Time:
- 2020-09-24 16:21:08
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1662524 | Akcea Therapeutics Inc. | AKCA | Pharmaceutical Preparations (2834) | 472608175 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1791857 | Kyle Jenne | C/O Akcea Therapeutics, Inc. 22 Boston Wharf Road, 9Th Floor Boston MA 02210 | Chief Commercial Officer | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Disposition | 2020-09-22 | 720 | $18.12 | 52,012 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | S | Direct |
Footnotes
- Sale of shares of common stock to cover tax withholding obligations associated with the vesting of a Restricted Stock Unit Award granted to the Reporting Person on September 19, 2019.
Billionaire Hedge Funds
